Previous 10 | Next 10 |
Summary UNH is where smart money went this year, gaining popularity as a defensive play in light of recent macroeconomic disruptions, underpinned by its predictable revenue stream and market position. However, it seems that this defensive play has been exhausted. UNH trades above ...
Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the second quarter, the Baron Discovery Fund was down 22.66% (Institutional Shares), which was 3.41% below the Russell...
Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund was down 18.60% (Institutional Shares) in the second quarter 2022. The economy is slowing, as we...
Progyny, Inc. (PGNY) Q2 2022 Earnings Conference Call August 4, 2022 04:45 PM ET Company Participants James Hart - Vice President of Investor Relations Peter Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Offic...
More companies in the U.S. are offering fertility benefits to employees to attract/retain talent and advance the diversity, equity, and inclusion agenda. PGNY has singled itself out as a pure-play fertility benefits management company, building an enviable client roster with 273 clien...
Gainers: Cooper-Standard Holdings ( CPS ) +78% . Highway Holdings ( HIHO ) +62% . Pineapple Energy ( PEGY ) +53% . Intelligent Living ( ILAG ) +55% . Progyny ( PGNY ) +41% . Global Blood Therapeutics ( GBT ) +38% . ...
Gainers: Allied Healthcare Products ( AHPI ) +30% . Progyny ( PGNY ) +28% . Kazia Therapeutics ( KZIA ) +21% . Selecta Biosciences ( SELB ) +18% . Sensus Healthcare ( SRTS ) +17% . Losers: Quoin Pharmaceuticals ( QNRX...
Progyny ( PGNY ) is trading ~18% higher post market after reporting a beat in Q2 consensus and raising the lower end of FY22 guidance. PGNY's Q2 GAAP EPS of $0.09 beats by $0.05 and revenue of $195M (+51.6% Y/Y) beats by $4.49M. The increase is primarily a resu...
Reports Record Quarterly Revenue of $195.0 Million, Reflecting 52% Growth Over the Prior Year Period Seeing Strong Employer Demand for Fertility and Family Building Benefit Solutions Raises Lower End of Full Year 2022 Guidance Ranges Issues Revenue Guidance of $190.0 to $197.0 Million...
NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Progyny is the first, and only, fertility benefits solution to publicly publish its clinical...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today released findings from its 2024 LGBTQ+ family building survey. The report, which surveyed over 1,100 LGBTQ+ individuals in the ...